Literature DB >> 27885635

Astroglia, Glutamatergic Transmission and Psychiatric Diseases.

Alexei Verkhratsky1,2,3, Luca Steardo4, Liang Peng5, Vladimir Parpura6.   

Abstract

Astrocytes are primary homeostatic cells of the central nervous system. They regulate glutamatergic transmission through the removal of glutamate from the extracellular space and by supplying neurons with glutamine. Glutamatergic transmission is generally believed to be significantly impaired in the contexts of all major neuropsychiatric diseases. In most of these neuropsychiatric diseases, astrocytes show signs of degeneration and atrophy, which is likely to be translated into reduced homeostatic capabilities. Astroglial glutamate uptake/release and glutamate homeostasis are affected in all forms of major psychiatric disorders and represent a common mechanism underlying neurotransmission disbalance, aberrant connectome and overall failure on information processing by neuronal networks, which underlie pathogenesis of neuropsychiatric diseases.

Entities:  

Keywords:  Astrocyte; Glutamate synthesis; Glutamatergic transmission; Major depression; Neuropathology; Neurotransmitter receptors; Psychiatric diseases; Schizophrenia

Mesh:

Substances:

Year:  2016        PMID: 27885635     DOI: 10.1007/978-3-319-45096-4_12

Source DB:  PubMed          Journal:  Adv Neurobiol


  7 in total

1.  Modified Mediterranean Diet for Enrichment of Short Chain Fatty Acids: Potential Adjunctive Therapeutic to Target Immune and Metabolic Dysfunction in Schizophrenia?

Authors:  Jamie Joseph; Colin Depp; Pei-An B Shih; Kristen S Cadenhead; Geert Schmid-Schönbein
Journal:  Front Neurosci       Date:  2017-03-27       Impact factor: 4.677

2.  Blocking Astrocytic GABA Restores Synaptic Plasticity in Prefrontal Cortex of Rat Model of Depression.

Authors:  Ipsit Srivastava; Erika Vazquez-Juarez; Lukas Henning; Marta Gómez-Galán; Maria Lindskog
Journal:  Cells       Date:  2020-07-16       Impact factor: 6.600

Review 3.  Neurointegrity and neurophysiology: astrocyte, glutamate, and carbon monoxide interactions.

Authors:  Vicki L Mahan
Journal:  Med Gas Res       Date:  2019 Jan-Mar

4.  Chronic Oral Palmitoylethanolamide Administration Rescues Cognitive Deficit and Reduces Neuroinflammation, Oxidative Stress, and Glutamate Levels in A Transgenic Murine Model of Alzheimer's Disease.

Authors:  Sarah Beggiato; Maria Cristina Tomasini; Tommaso Cassano; Luca Ferraro
Journal:  J Clin Med       Date:  2020-02-05       Impact factor: 4.241

Review 5.  Astroglial correlates of neuropsychiatric disease: From astrocytopathy to astrogliosis.

Authors:  Ronald Kim; Kati L Healey; Marian T Sepulveda-Orengo; Kathryn J Reissner
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-10-06       Impact factor: 5.067

6.  Oxytocin Rapidly Changes Astrocytic GFAP Plasticity by Differentially Modulating the Expressions of pERK 1/2 and Protein Kinase A.

Authors:  Ping Wang; Danian Qin; Yu-Feng Wang
Journal:  Front Mol Neurosci       Date:  2017-08-15       Impact factor: 5.639

7.  Ultramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer's disease by exerting anti-inflammatory and neuroprotective effects.

Authors:  Caterina Scuderi; Maria Rosanna Bronzuoli; Roberta Facchinetti; Lorenzo Pace; Luca Ferraro; Kevin Donald Broad; Gaetano Serviddio; Francesco Bellanti; Gianmauro Palombelli; Giulia Carpinelli; Rossella Canese; Silvana Gaetani; Luca Steardo; Luca Steardo; Tommaso Cassano
Journal:  Transl Psychiatry       Date:  2018-01-31       Impact factor: 6.222

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.